Samjin Pharmaceutical's largest shareholder Jo Ui-hwan plans to gift 270,000 shares to family, reducing stake from 6.30% to 4.28%
Jo Ui-hwan, the de facto controlling shareholder of Samjin Pharmaceutical, reported a plan to gift a total of 270,000 common shares to his children Jo Gyu-seok and Jo Gyu-hyeong on August 10, 2026, with 135,000 shares each.
The gift is intended for succession of the controlling stake. After the transaction, Jo's ownership will decrease from 6.30% to 4.28%. Total outstanding shares remain unchanged, so no dilution for existing shareholders.
[AI Summary]This transaction is a personal succession plan by the largest shareholder, unrelated to corporate capital changes or fundraising, thus neutral to shareholder value. However, the reduction in the controlling stake may warrant attention regarding management stability.
KOSPI Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders